Abstract:Acrylamide exposure along with resultant potential adverse health effects have attracted global concern, and the World Health Organization calls for more and urgent studies on the health risks from acrylamide. However, the association and mechanism between acrylamide exposure and pulmonary dysfunction remain unclear. Our goals were to investigate the relationship of internal acrylamide exposure with lung function reduction, and the potential mediating role of systematic inflammation in that relationship. Our study was conducted within the Wuhan-Zhuhai cohort. Urinary biomarkers of acrylamide exposure (N-acetyl-S-(2-carbamoylethyl)-l-cysteine, AAMA; N-acetyl-S-(2-carbamoyl-2-hydroxyethyl)-l-cysteine, GAMA) and lung function were determined among 3271 general adults, of whom 2595 had test results of systemic inflammatory marker plasma C-reactive protein (CRP). We employed linear mixed models to assess the relations among urinary acrylamide metabolites, pulmonary function and plasma CRP, and PRODCLIN program to evaluate the mediating role of CRP. We observed that urinary acrylamide metabolites were inversely and dose-dependently related to lung function (P trend<0.05). Each 1-unit increment in log-transformed level of AAMA, GAMA, or AAMA+GAMA (ΣUAAM) was significantly (P < 0.05) related to a 59.9-, 64.2-, or 64.3-mL reduction in FVC, and a 53.9-, 59.7-, or 58.5-mL reduction in FEV1, respectively. Such relationships were independent of smoking, and were significant in physically inactive rather than physically active participants. AAMA (β = 0.10), GAMA (β = 0.16) and ΣUAAM (β = 0.12) were significantly (P < 0.05) related to increased CRP, which was significantly (P < 0.05) related to reduced FVC (β = −55.3) and FEV1 (β = −40.6). We further found that increased CRP significantly (P < 0.05) mediated 6.34–11.1% of the urinary acrylamide metabolites-associated lung function reductions. For the first time, our findings suggested that exposure to acrylamide in daily life was related to reduced lung function and increased systemic inflammation in general population, and systemic inflammation further mediated acrylamide-associated lung function reduction, indicating a potential mechanistic role of systemic inflammation underlying pulmonary dysfunction from acrylamide exposure.

Acrylamide Exposure and Oxidative DNA Damage, Lipid Peroxidation and Fasting Plasma Glucose Alteration: Association and Mediation Analyses in Chinese Urban Adults

Relationships Between Acrylamide and Glycidamide Hemoglobin Adduct Levels and Allergy-Related Outcomes in General Us Population, Nhanes 2005-2006

Acrylamide exposure and pulmonary function reduction in general population: The mediating effect of systemic inflammation

Toxicokinetics and Internal Exposure of Acrylamide: New Insight into Comprehensively Profiling Mercapturic Acid Metabolites As Short-Term Biomarkers in Rats and Chinese Adolescents.

Exposure to acrylamide and increased risk of depression mediated by inflammation, oxidative stress, and alkaline phosphatase: Evidence from a nationally representative population-based study

Exposure to acrylamide and reduced heart rate variability: The mediating role of transforming growth factor-β

Acrylamide exposure increases cardiovascular risk of general adult population probably by inducing oxidative stress, inflammation, and TGF-β1: A prospective cohort study

Arsenic exposure incurs hyperglycemia mediated by oxidative damage in urban adult population: A prospective cohort study with three repeated measures

Exposure to Acrylamide and the Risk of Cardiovascular Diseases in the National Health and Nutrition Examination Survey 2003–2006

Association of Acrylamide Hemoglobin Biomarkers with Obesity, Abdominal Obesity and Overweight in General US Population: NHANES 2003-2006

Machine Learning Prediction of Exposure to Acrylamide Based on Modelling of Association Between Dietary Exposure and Internal Biomarkers.

Protective effect of a dietary flavonoid-rich antioxidant from bamboo leaves against internal exposure to acrylamide and glycidamide in humans

Associations of Acrylamide with Non-Alcoholic Fatty Liver Disease in American Adults: a Nationwide Cross-Sectional Study

Associations of Hemoglobin Adducts of Acrylamide and Glycidamide with Prevalent Metabolic Syndrome in a Nationwide Population-Based Study.

Cross-sectional and longitudinal associations of acrolein exposure with pulmonary function alteration: Assessing the potential roles of oxidative DNA damage, inflammation, and pulmonary epithelium injury in a general adult population

The association between biomarkers of acrylamide and cancer mortality in U.S. adult population: Evidence from NHANES 2003-2014

Research progress in biomarker analysis and risk assessment of acrylamide exposure in vivo

Associations of Hemoglobin Biomarker Levels of Acrylamide and All-Cause and Cardiovascular Disease Mortality among U.S. Adults: National Health and Nutrition Examination Survey 2003–2006

Biomarker Analysis of Hemoglobin Adducts of Acrylamide and Glycidamide Enantiomers for Mid-Term Internal Exposure Assessment by Isotope Dilution Ultra-High Performance Liquid Chromatography Tandem Mass Spectrometry.

Unraveling the Serum Metabolomic Profile of Acrylamide-Induced Cardiovascular Toxicity

Association of acrylamide hemoglobin biomarkers with chronic obstructive pulmonary disease in the general population in the US: NHANES 2013-2016.